XIN GUAN: Open Payments
NPI 1780918706 · CHESTER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,421 in 126 payments from 21 companies in 2025. Trend: 2023 $1,787 · 2024 $2,427 · 2025 $2,421
Food & beverage: $2,234Education: $187
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $412 |
| ABBVIE INC. | 26 | $303 |
| Galderma Laboratories, L.P. | 18 | $254 |
| Janssen Biotech, Inc. | 6 | $186 |
| PFIZER INC. | 10 | $177 |
| Amgen Inc. | 10 | $176 |
| Lilly USA, LLC | 8 | $138 |
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| LEO Pharma Inc. | 5 | $96 |
| GENZYME CORPORATION | 4 | $81 |
Products named: DUPIXENT, TREMFYA, Otezla, SKYRIZI, NEMLUVIO, RINVOQ, CIBINQO, Rhapsido.
Industry payments across NJ — which companies pay providers there.
